The U.S. Food and Drug Administration (FDA) has begun a new phase in its post-market assessment of phthalates used in food-contact materials, signalling that packaging manufacturers may soon face stricter scrutiny over some of the chemicals used to improve the flexibility and durability of plastic packaging. While the review does not introduce immediate restrictions, it could influence future regulatory decisions and encourage the industry to accelerate its transition towards alternative materials.

Phthalates have been used for decades as plasticisers in a wide range of products, including certain food-contact materials, processing equipment and flexible plastic applications. Concerns about their potential impact on human health, particularly regarding endocrine disruption, have led regulators worldwide to reassess their safety. In May 2026, the FDA released a scientific evaluation proposing that four authorised ortho-phthalates should be grouped together for a future cumulative risk assessment, marking an important change in the agency's approach. :contentReference[oaicite:0]{index=0}

Rather than evaluating each substance independently, the FDA is now considering whether certain phthalates should be assessed collectively because of their similar chemical and biological properties. The outcome could eventually affect the authorisation of specific food-contact applications, although no immediate bans or product recalls have been announced. :contentReference[oaicite:1]{index=1}

Although the review remains ongoing, packaging manufacturers, converters and food producers are unlikely to wait for a final regulatory decision before reviewing their material portfolios. Many multinational brands have already reduced their reliance on phthalate-containing materials over recent years, driven by customer requirements, retailer specifications and sustainability commitments. For suppliers that still use authorised phthalates, the FDA review highlights the importance of maintaining detailed documentation on formulation, compliance and material traceability.

Companies may also begin evaluating alternative plasticisers or redesigning packaging structures that reduce or eliminate the need for these additives altogether. This process can require extensive validation to ensure that replacement materials continue to meet food safety, migration, sealing and performance requirements.

The FDA review is being closely monitored outside the United States because many packaging manufacturers operate globally. Regulatory developments in one major market often influence purchasing decisions, supplier qualification processes and future product development elsewhere. Companies supplying international food brands may therefore choose to harmonise material specifications across multiple regions rather than maintaining different formulations for different markets.

As consumer expectations continue to evolve and chemical safety receives greater regulatory attention, packaging innovation is increasingly focused on combining high performance with simpler, more transparent material compositions. Whether or not the FDA ultimately changes current authorisations, the ongoing review is expected to accelerate investment in next-generation food-contact materials that can satisfy both regulatory requirements and long-term sustainability objectives.